$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
瑞士罗氏美罗华治疗淋巴瘤多少钱
2025-10-19 11:44:20
Check Details
瑞士罗氏美罗华治疗淋巴瘤怎么样
2025-10-19 11:44:20
Check Details
瑞士罗氏美罗华治疗淋巴瘤效果好吗
2025-10-19 11:44:20
Check Details
瑞士罗氏美罗华适合哪几种淋巴瘤
2025-10-19 11:44:20
Check Details
瑞士罗氏美罗华治疗淋巴瘤效果如何
2025-10-19 11:44:20
Check Details
治疗淋巴瘤的用药方案都有哪些
2025-10-19 11:44:20
Check Details
治疗淋巴瘤只能用瑞士罗氏美罗华吗
2025-10-19 11:44:20
Check Details
瑞士罗氏美罗华杀死B细胞还会再生吗
2025-10-19 11:44:20
Check Details
瑞士罗氏美罗华在淋巴瘤治疗中的应用
2025-10-19 11:44:20
Check Details
瑞士罗氏美罗华治疗恶性淋巴瘤护理分析
2025-10-19 11:44:20
Check Details
首个罕见血管炎药物瑞士罗氏美罗华获批了
2025-10-19 11:44:20
Check Details
瑞士罗氏美罗华在中国多少钱
2025-10-19 11:44:20
Check Details
1
2
...
1252
1253
1254
1255
1256
1257
1258
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
2
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
3
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
4
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
5
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
6
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
7
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
8
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity
9
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
10
Tucatinib HER2 TKI: With Trastuzumab + Capecitabine, Diarrhea and Hepatotoxicity Monitoring
11
Pemigatinib for FGFR2-Rearranged Cholangiocarcinoma: Eligibility, Response Limits, Hyperphosphatemia and Ocular Monitoring
12
Cabozantinib with Aspirin: Additive Bleeding Risk, Do Not Stop Cardiac Aspirin Alone, Urgent Warning Signs